A critical breakthrough in cancer investigation is arising with the use of nanobodies to reactivate dysfunctional p53. This crucial malignant protector protein is frequently inactivated in several forms of tumors, https://bookmarkport.com/story24835734/vhh-fragments-reactivate-the-p53-protein-new-new-hope-for-malignant-therapy